Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 21 February 2027
- Last conf. stmt
- 7 February 2026
Apcintex Limited
- Incorporated
- 16 June 2014 (12 years)
- Previously known as
- Serpin Haemostatics Limited (until 2 April 2016)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Accounts type
- Small
- Region
- South East
- Address
- Lilly House BasingviewBasingstokeHampshireRG21 4FA
Charges
- Total
- 4
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 4
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 24 June 2026
American
Born February 1979 (47)
Director · Appointed 24 June 2026
American
Born November 1978
Corporate Secretary · Appointed 30 November 2021
Officer history (14 former)
24 June 2026
24 June 2026
24 June 2026
24 June 2026
24 June 2026
4 July 2025
1 July 2025
21 June 2024
17 August 2023
1 November 2022
31 July 2022
30 November 2021
30 November 2021
30 November 2021
1 November 2021
29 January 2021
29 January 2021
29 January 2021
29 January 2021
Resigned Huntington, James Andrew, Professor as Director
29 January 2021
29 January 2021
29 January 2021
5 April 2018
5 April 2018
Resigned Bach Gonzalez, Daniel, Dr as Director
7 December 2016
7 December 2016
7 December 2016
Appointed Huntington, James Andrew, Professor as Director
7 December 2016
Appointed Bach Gonzalez, Daniel, Dr as Director
16 June 2014
16 June 2014
16 June 2014
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 20 December 2022
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited By Shares
Reg. no. 13040752
Former controllers (2)
20 December 2022
Ceased Centessa Pharmaceuticals PLC — Owns 75–100% of shares
29 January 2021
Ceased Touchstone Innovations Businesses LLP — Owns 25–50% of shares
Group structure 3 companies
Ownership group derived from the Companies House PSC register
Centessa Pharmaceuticals (UK) Limited Owns 75–100% of shares
Apcintex Limited This company Owns 75–100% of shares
Financials
Figures from 2020 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Cash
- £11,048,377
- up £6,326,809 (134%)
- Employees
- 2
- no change
- Current Ratio
- 27.2x
Trend
Shareholder Funds
Balance sheet detail
| 2020 | 2019 | |
|---|---|---|
| Current Assets | £12,125,142 | £7,235,771 |
| Debtors | £1,076,765 | £2,514,203 |
| Cash | £11,048,377 | £4,721,568 |
| Creditors (< 1 year) | £445,209 | £753,069 |
| Net Current Assets | £11,679,933 | £6,482,702 |
| Shareholder Funds | £11,679,933 | £6,482,702 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 9 September 2026 | Change of details for a person with significant control |
Some other companies at this address
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →